Skip to Main Content

Try STAT+ TODAY

advocacy

Most Read

First Opinion Andrea L. Cox

A challenge trial can streamline testing of hepatitis C vaccines

First Opinion Stacy Bratcher

Health care needs a Black Friday sale: the case for legalizing discounts on medical services

First Opinion Paul Amadeus Lane and Jim Meade

Medicare needs to update its wheelchair coverage for the 21st century

First Opinion Steve Pearson

Launch prices: tackling the next drug pricing challenge

First Opinion H. Gilbert Welch

Congress should not compel Medicare to pay for liquid biopsies

First Opinion S. Monica Soni

People with terminal cancer need to know they are dying. Doctors shouldn’t withhold that information

First Opinion Dariush Mozaffarian and David B. Waters

‘Food is medicine’ interventions should be the main course at White House nutrition conference

First Opinion William G. Woods

As a pediatric cancer researcher, I admired the FDA. Then I got ALS

All Coverage

First Opinion Judy Monroe

Public health agencies: learn from NASA about regaining the public’s trust

First Opinion Jammie Law, Michael Pillinger and Julie Nusbaum

Termination is the safest course for some high-risk pregnancies. Dobbs decision threatens that care

advertisement

Politics Rachel Cohrs

Patients for Affordable Drugs taps new leader

First Opinion Steven Roach

FDA and USDA need to get on board with the CDC about reducing antibiotic use in raising animals for food

First Opinion Podcast Patrick Skerrett

Listen: A doctor with ALS laments the slow pace for drug approval

First Opinion Karen Quandt

The FDA needs to be more flexible in assessing treatments for rare diseases, like the one that seemed to help my son

First Opinion Elizabeth Mitchell and Mike Thompson

As hospitals raise their prices, U.S. workers and businesses suffer

First Opinion Sallie Permar and Jay K. Varma

Polio in New York: A call to action for U.S. pediatricians and public health to work together

First Opinion David Stein

Monkeypox public health response is lagging for LGBTQ+ community

First Opinion Susannah Baruch

The Biden-Harris administration needs to end fake abortion clinics

First Opinion Ofole Mgbako

History doesn’t have to repeat itself with stigma and monkeypox

First Opinion Ned Calonge, Jane Hoppin and Alex R. Kemper

Report: More people should be tested for potential exposure to ‘forever chemicals’

Politics Rachel Cohrs

In a momentous vote for Pelosi, House sends drug pricing reforms to President Biden’s desk

Business Bob Herman

Health care industry swarms Washington as surprise billing rules get ironed out

D.C. Diagnosis Edward Chen

A chaotic sprint to lower insulin prices and AIDS activists go after Biden on monkeypox

D.C. Diagnosis Rachel Cohrs

The view on drug pricing from Wall Street, a pharma-friendly Dem holds firm, and what’s next for a big telehealth bill

First Opinion Irene Shapiro

The Morris ALS Principles: A model for empowering all disease communities

First Opinion Kip Sullivan, Ana Malinow and Kay Tillow

Value-based payment has produced little value. It needs a time-out

First Opinion Kira Sampson, Carlise Sorenson and Kate Adamala

The FDA needs to get ready to evaluate synthetic cells, the next generation of therapeutics

Politics Rachel Cohrs

‘What can we do?’: Pharma lobbyists face their biggest test in a decade, as Democrats barrel toward a vote on drug pricing

First Opinion Jeeshan Chowdhury

Working with Indigenous allies is the ethical way to develop psychedelic-based pharmaceuticals

D.C. Diagnosis Nicholas Florko

PhRMA and BIO descend on D.C. & unpacking the Senate’s FDA funding drama

First Opinion Lora Council

Keep equity in mind when moving to value-based payment

First Opinion Halle Tecco

Free the pill — and make it free

Politics Nicholas Florko

Major abortion pill maker GenBioPro hires its first lobbyists in Washington